DuPont de Nemours, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $DD in the last 30 days.
See all $DD insider activity →DuPont (DD) introduced AmberChrom SIL, a silica gel for peptide purification, targeting GLP-1 receptor agonists. The product supports workflows and scalability, aligning with growing demand in the peptide market.
DuPont (DD) declared a $0.60 per share quarterly dividend, maintaining the previous rate. The forward yield is 1.85%. The dividend is payable on December 15 to shareholders of record on November 30, with an ex-dividend date of November 30.
JPMorgan downgraded DuPont de Nemours to 'Neutral' from 'Overweight' and set a $145 price target. The company's stock is currently at $130.56, up 0.43% on the day but down 0.05% year-to-date. This move may impact investor sentiment and trading activity.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning DD (DuPont de Nemours, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent DD coverage spans financial news, corporate actions and earnings.
The launch adds a niche chromatography product but lacks disclosed revenue or contract size.
Dividend confirmation may provide modest support to the stock but no change to payout policy.
Downgrade and lower target imply reduced expected returns versus prior positioning, likely pressuring sentiment and near-term relative performance.
Small exchange transaction; negligible effect.
Downgrade may weigh on stock.
AlphAI scores every news story that mentions DD with an AI model for sentiment and relevance, and aggregates insider trades from DuPont de Nemours, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
DuPont (DD) introduced AmberChrom SIL, a silica gel for peptide purification, targeting GLP-1 receptor agonists. The product supports workflows and scalability, aligning with growing demand in the peptide market.
2 min readDuPont (DD) declared a $0.60 per share quarterly dividend, maintaining the previous rate. The forward yield is 1.85%. The dividend is payable on December 15 to shareholders of record on November 30, with an ex-dividend date of November 30.
1 min readJPMorgan downgraded DuPont de Nemours to 'Neutral' from 'Overweight' and set a $145 price target. The company's stock is currently at $130.56, up 0.43% on the day but down 0.05% year-to-date. This move may impact investor sentiment and trading activity.
2 min readDaniel S. Sullivan disclosed stock trades, including selling shares of Constellation Energy (CEG) and Exelon (EXC) in May 2023, and selling shares of Corteva (CTVA), Dow (DOW), IFF, Oracle (ORCL), and DuPont (DD) in early 2021. The transaction amounts ranged from $1,001 to $50,000.
1 min readBaird upgraded Humana (HUM) to Outperform with a $596 price target, citing 2028 EPS confidence. Oppenheimer upgraded Fastly (FSLY) to Outperform with a $35 target, noting AI traffic growth. Monness Crespi upgraded Elastic (ESTC) to Buy with a $120 target, praising execution. Morgan Stanley double-upgraded Cboe (CBOE) to Overweight with a $358 target, citing S&P contract renewal. Barclays initiated SpaceX (SPCX) with Overweight and $254 target, calling it an industrial revolution play.
3 min readJPMorgan downgraded DuPont (NYSE:DD) to Neutral from Overweight, lowering its price target to $145 from $172. The stock trades at $132.48, considered undervalued. DuPont reported Q2 2026 earnings, beating estimates with $1.88 EPS and $1.82B revenue. BMO Capital reiterated its Outperform rating, maintaining a $186 price target.
2 min readDuPont (NYSE: DD) plans to release its Q3 2026 earnings on November 3, 2026, at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET. The event will be webcast live and a replay will be available on the company's Investor Relations webpage.
1 min readIndiana Attorney General Todd Rokita, along with 16 other states, sued DuPont (EIDP), Corteva, and Vylor over a $40 billion asset transfer allegedly aimed at avoiding PFAS contamination liabilities. The lawsuit seeks to block the transfer, claiming it shields assets from potential damages. Corteva denies the allegations, calling the lawsuit meritless.
2 min readAttorney General Todd Rokita led a 16-state lawsuit against DuPont (EIDP), Corteva, and Vylor, alleging a transfer of assets to avoid PFAS contamination liabilities. The suit seeks to freeze assets and block dividends or buybacks. Rokita claims the companies moved valuable assets to Vylor, leaving liabilities with DuPont. The hearing is set for October 2, 2026.
2 min readDuPont de Nemours (DD) launched the Sugar Separation Advisor, a tool for sugar producers. Its stock is down short-term but up 34.67% over one year. Analysts debate its valuation, with some seeing it as 24% undervalued at $129.89, while others note a high P/E of 57.4x. The company faces PFAS legal risks and relies on cost cuts.
2 min read
